Page 49 - பாஷ் ஆரோக்கியம் நிறுவனங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article NEW YORK, April 1, 2021 /PRNewswire/ The anti-obesity drugs market is poised to grow by $ 454.51 mn during 2021-2025, decelerating at a CAGR of 5% during the forecast period.  Technavio has announced its latest market research report titled Anti-obesity Drugs Market by Type, Mechanism Action, and Geography - Forecast and Analysis 2021-2025 View Our Exclusive report on Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. The report on the anti-obesity drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. There is an increasing need for drugs that show sustained, long-term efficacy, which, in turn, is providing immense opportunities for vendors in the market to come up with innovative products. The market is driven by a limited numb

United statesUnited kingdomJesse maidaBausch health companies incRoche ltdGelesis incGlaxosmithkline plcTechnavio researchTeva pharmaceutical industries ltdMarine pharmaceuticals marketRhythm pharmaceuticals incCurrax pharmaceuticalsHealth careNovo nordiskView our exclusiveClosure devices market